DK0650736T3 - Fremgangsmåde til sterilisering af et farmaceutisk præparat af rekombinant humant serumalbumin - Google Patents

Fremgangsmåde til sterilisering af et farmaceutisk præparat af rekombinant humant serumalbumin

Info

Publication number
DK0650736T3
DK0650736T3 DK94116937T DK94116937T DK0650736T3 DK 0650736 T3 DK0650736 T3 DK 0650736T3 DK 94116937 T DK94116937 T DK 94116937T DK 94116937 T DK94116937 T DK 94116937T DK 0650736 T3 DK0650736 T3 DK 0650736T3
Authority
DK
Denmark
Prior art keywords
sterilizing
serum albumin
human serum
pharmaceutical preparation
recombinant human
Prior art date
Application number
DK94116937T
Other languages
Danish (da)
English (en)
Inventor
Tomoshi Ohya
Shinobu Kuwae
Kenji Tomomitsu
Kaoru Kobayashi
Takao Ohmura
Toyoo Ohda
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17468634&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0650736(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Application granted granted Critical
Publication of DK0650736T3 publication Critical patent/DK0650736T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK94116937T 1993-10-27 1994-10-26 Fremgangsmåde til sterilisering af et farmaceutisk præparat af rekombinant humant serumalbumin DK0650736T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5269168A JPH07126182A (ja) 1993-10-27 1993-10-27 組換えヒト血清アルブミン製剤の滅菌方法

Publications (1)

Publication Number Publication Date
DK0650736T3 true DK0650736T3 (da) 2000-08-28

Family

ID=17468634

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94116937T DK0650736T3 (da) 1993-10-27 1994-10-26 Fremgangsmåde til sterilisering af et farmaceutisk præparat af rekombinant humant serumalbumin

Country Status (8)

Country Link
US (1) US5691451A (es)
EP (1) EP0650736B1 (es)
JP (1) JPH07126182A (es)
KR (1) KR100371045B1 (es)
CA (1) CA2134535C (es)
DE (1) DE69425033T2 (es)
DK (1) DK0650736T3 (es)
ES (1) ES2149230T3 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0770676A3 (en) * 1995-10-23 1999-05-19 Ajinomoto Co., Ltd. Method for treating fermentation broth
EP0995419B1 (en) 1998-10-21 2005-12-21 Nipro Corporation Method for producing a plastic vessel containing an albumin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
US6493867B1 (en) 2000-08-08 2002-12-10 Ball Semiconductor, Inc. Digital photolithography system for making smooth diagonal components
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
JP4798832B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
JP4798833B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 加熱処理工程を含むヒト血清アルブミンの製造方法
US6730286B2 (en) * 2001-02-28 2004-05-04 Bracco Diagnostics, Inc. Manufacturing process to control particle size
AU2004228847B2 (en) * 2003-04-09 2010-06-17 Km Biologics Co., Ltd. Process for producing albumin preparation
AU2005205314B2 (en) 2004-01-20 2010-12-09 Km Biologics Co., Ltd. Process for producing human serum albumin by heating in presence of divalent cation
EP2471557A1 (en) * 2010-12-27 2012-07-04 Università degli Studi di Genova A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid useful for the localization of radionuclides for diagnostic and therapeutic purposes
CN103923211A (zh) * 2014-05-08 2014-07-16 齐智 一种医药级重组人血清白蛋白的纯化方法
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido
EP3240798B8 (en) * 2015-01-01 2020-03-25 Shilpa Medicare Limited Novel method for efficient purification of human serum albumin
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8628104D0 (en) * 1986-11-25 1986-12-31 Connaught Lab Pasteurization of immunoglobin solutions
FR2630115B1 (fr) * 1988-04-14 1994-10-28 Merieux Inst Procede de stabilisation des solutions d'albumine humaine et solution obtenue
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JP3230091B2 (ja) * 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
JPH0671432B2 (ja) * 1991-03-20 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
JPH07102147B2 (ja) * 1992-03-16 1995-11-08 株式会社ミドリ十字 ヒト血清アルブミンの着色抑制方法

Also Published As

Publication number Publication date
CA2134535A1 (en) 1995-04-28
US5691451A (en) 1997-11-25
ES2149230T3 (es) 2000-11-01
KR100371045B1 (ko) 2003-03-19
KR950010898A (ko) 1995-05-15
DE69425033T2 (de) 2001-03-08
DE69425033D1 (de) 2000-08-03
JPH07126182A (ja) 1995-05-16
EP0650736B1 (en) 2000-06-28
CA2134535C (en) 2004-06-08
EP0650736A1 (en) 1995-05-03

Similar Documents

Publication Publication Date Title
DK0570916T3 (da) Fremgangsmåde til rensning af humant rekombinant serumalbumin
DK0650736T3 (da) Fremgangsmåde til sterilisering af et farmaceutisk præparat af rekombinant humant serumalbumin
DK180790A (da) Fremstilling af farmaceutisk praeparat
DK362189D0 (da) Farmaceutisk praeparat til intravenoes indgift
NO922005D0 (no) Farmasoeytiske preparater
DE69622735D1 (de) Lyophilisierte stabile pharmazeutische formulierung
NO954146D0 (no) Belagte farmasöytiske preparater
DK0509122T3 (da) Indretning til transdermal administration af protein- eller peptidmedikamenter
NO943888D0 (no) Farmasöytisk preparat
DK0420007T3 (da) Fremgangsmåde til rensning af human serumalbumin
DK148092D0 (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat til selektiv nedsaettelse af lipidniveauet i blodet
DK184890A (da) Anvendelse af anti-t-celle-immunotoxin til fremstilling af farmaceutiske praeparater til behandling af autoimmune sygdomme
KR900700492A (ko) N-헤테로사이클릭 프로필리덴-1,1-비스포스폰산, 이의 제조방법 및 약제학적 조성물
IT8922164A0 (it) Composizione farmaceutica e procedimento per la sua preparazione
DK0656419T3 (da) Fremgangsmåde til højrensning af humant serumalbumin
DK0504823T3 (da) Fremgangsmåde til fremstilling af human serumalbumin
DK28795A (da) Insulinholdigt polymerpræparat til oral administrering af insulin
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
DK0591605T3 (da) Fremgangsmåde til undertrykkelse af farvning af humant serumalbumin
DK0655503T3 (da) Fremgangsmåde til fremstilling af humant serumalbumin
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
DK0658569T3 (da) Fremgangsmåde til affarvning af humant serumalbumin
DK13087A (da) Gensekvens til fremstilling af human serumalbumin i bacillus
KR950702115A (ko) 디히드로피리딘 유도체의 신규 의약 용도(novel medicinal use of dihydropyridine derivative)
DK244489D0 (da) Fremgangsmaade til terapeutisk administration af laegemidlet l-deprenyl